Susquehanna International Group, LLP Oncorus, Inc. Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	BUY	$0.28 - $0.45 $4,907 - $7,886	17,525 New	17,525 $5,000
Q2 2022 Aug 15, 2022	BUY	$1.04 - $1.86 $42,839 - $76,617	41,192 New	41,192 $52,000
Q1 2022 May 16, 2022	SELL	$1.44 - $5.62 $15,618 - $60,954	-10,846 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.03 - $11.63 $54,555 - $126,138	10,846 New	10,846 $57,000
Q2 2021 Aug 11, 2021	SELL	$13.3 - $17.3 $467,229 - $607,749	-35,130 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$11.89 - $35.55 $417,695 - $1.25 Million	35,130 New	35,130 $489,000

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.